Financials

  • Market Capitalization 82.22 M
  • Employee 112
  • Founded 1999
  • CEO Jacqueline Shea
  • Website www.inovio.com
  • Headquarter Delaware, United States
  • FIGI BBG000BK6YX5
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.96
Fiyat/satışlar oranı
1 248.52

Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development.

Haberler